跳到正文
Longevity.Technology (@LongevityTech)· LongevityTech·· 3 天前评分17

Digbi Health称替尔泊肽用户减重优于已发表队列

Digbi Health says members on tirzepatide lost more than published cohorts, but the comparison comes with fine print.

导读

Digbi Health称,使用替尔泊肽的会员减重效果超过已发表的队列,但这一比较附有细则说明。 https://vist.ly/5tgyc #longevity #metabolichealth #tirzepatide #weightloss #digitalhealth

来源:Longevity.Technology (@LongevityTech) · x.com